NATCO Pharma rights issue offers a clear opportunity for investors looking to capitalize on the recent ₹1,279.36 crore approval.
Read More
Telix ITM Acquisition: The Best Proven Strategy for Pharma Growth
Telix ITM acquisition highlights the latest trends in radiopharmaceutical dealmaking and its impact on the pharma industry.
Read More